Labcorp Holdings Inc. (LH)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $30.08B
Last updated: Nov 17, 2026 at 11:06 AM ET
Labcorp Holdings Inc. (LH) Financials: Revenue, Profit and Cash Flow
Labcorp Holdings reported revenue of $13.95B for the fiscal year ended Dec 31, 2025, up 7.2% from the year before. That year, net income was $877.70M with a net margin of 6.3%, operating cash flow was $1.64B and free cash flow was $1.21B. The quarter ended Sep 30, 2026 had revenue of $3.81B and net income of $263.10M.
Revenue and Margins
The operating margin was 9.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $9.55B, a compound annual rate of 4.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $13.95B | +7.2% | 28.8% | 9.9% | 6.3% |
| Dec 2024 | $13.01B | +7.0% | 27.9% | 8.4% | 5.7% |
| Dec 2023 | $12.16B | +2.5% | 27.7% | 6.0% | 3.4% |
| Dec 2022 | $11.86B | -9.7% | 31.3% | 12.1% | 10.8% |
| Dec 2021 | $13.14B | -6.0% | 38.0% | 23.2% | 18.1% |
| Dec 2020 | $13.98B | +21.0% | 35.4% | 17.5% | 11.1% |
| Dec 2019 | $11.55B | +2.0% | 28.1% | 11.5% | 7.1% |
| Dec 2018 | $11.33B | +9.9% | 28.0% | 11.7% | 7.8% |
| Dec 2017 | $10.31B | +7.9% | 30.0% | 12.7% | 12.0% |
| Dec 2016 | $9.55B | N/A | 29.9% | 13.3% | 7.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 17.5% from the year before. In the quarter ended Sep 2026, net income rose 0.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B | $10.31B | $9.55B |
| Cost of revenue | $9.94B | $9.38B | $8.80B | $8.15B | $8.14B | $9.03B | $8.30B | $8.16B | $7.22B | $6.70B |
| Gross profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B | $3.25B | $3.18B | $3.09B | $2.85B |
| Operating income | $1.38B | $1.09B | $725.60M | $1.44B | $3.05B | $2.45B | $1.33B | $1.33B | $1.31B | $1.27B |
| Net income | $877.70M | $747.10M | $419.20M | $1.28B | $2.38B | $1.56B | $824.90M | $883.90M | $1.23B | $712.90M |
| EBITDA | $2.01B | $1.79B | $1.32B | $1.94B | $3.81B | $3.24B | $2.10B | $2.05B | $1.83B | $1.78B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.81B | $3.73B | $3.54B | $3.52B | $3.56B | $3.53B | $3.35B | $3.33B | $3.28B | $3.22B | $3.18B | $3.03B |
| Gross profit | $1.11B | $1.11B | $1.01B | $993.20M | $1.03B | $1.05B | $948.00M | $896.30M | $904.40M | $926.40M | $897.30M | $821.40M |
| Operating income | $402.10M | $451.60M | $380.80M | $267.60M | $396.60M | $394.50M | $326.00M | $216.50M | $254.10M | $294.80M | $321.30M | -$122.80M |
| Net income | $263.10M | $299.10M | $278.00M | $164.90M | $261.50M | $238.30M | $213.00M | $143.60M | $169.60M | $205.60M | $228.30M | -$166.80M |
Balance Sheet
As of Dec 2025, total debt of $5.58B exceeded cash and equivalents by $5.05B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.39B | $18.38B | $16.73B | $20.16B | $20.39B | $20.07B | $18.05B | $16.19B | $16.67B | $14.25B |
| Current assets | $4.02B | $4.81B | $3.77B | $4.63B | $5.33B | $5.13B | $2.98B | $2.84B | $2.73B | $2.48B |
| Cash and equivalents | $532.30M | $1.52B | $536.80M | $320.60M | $1.47B | $1.32B | $337.50M | $426.80M | $316.60M | $433.60M |
| Total liabilities | $9.76B | $10.31B | $8.83B | $10.06B | $10.09B | $10.61B | $10.46B | $9.19B | $9.76B | $8.73B |
| Short-term debt | $500.10M | $1.00B | $999.80M | $301.30M | $1.50M | $376.70M | $415.20M | $10.00M | $417.50M | $549.50M |
| Long-term debt | $5.08B | $5.33B | $4.05B | $5.04B | $5.42B | $5.42B | $5.79B | $5.99B | $6.34B | $5.30B |
| Shareholder equity | $8.62B | $8.05B | $7.88B | $10.10B | $10.27B | $9.44B | $7.57B | $6.97B | $6.82B | $5.52B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.92B | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | $17.60B | $18.38B | $18.61B | $16.71B | $16.53B | $16.73B |
| Total liabilities | $10.06B | $9.91B | $10.34B | $9.76B | $9.55B | $9.57B | $9.28B | $10.31B | $10.43B | $8.69B | $8.56B | $8.83B |
| Cash and equivalents | $261.80M | $141.80M | $981.10M | $532.30M | $598.10M | $647.30M | $369.40M | $1.52B | $1.52B | $265.10M | $99.30M | $536.80M |
| Shareholder equity | $8.85B | $8.61B | $8.73B | $8.62B | $8.70B | $8.47B | $8.31B | $8.05B | $8.17B | $8.01B | $7.96B | $7.88B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 73.8% of operating cash flow. Dividends and share repurchases together came to 57.1% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B | $2.14B | $1.44B | $1.31B | $1.50B | $1.20B |
| Capital expenditures | $434.50M | $489.90M | $453.60M | $429.30M | $421.50M | $381.70M | $400.20M | $379.80M | $312.90M | $278.90M |
| Free cash flow | $1.21B | $1.10B | $874.10M | $1.53B | $2.69B | $1.75B | $1.04B | $925.60M | $1.19B | $918.20M |
| Dividends paid | $240.70M | $243.10M | $254.00M | $195.20M | $1.00B | $151.70M | $2.40B | $467.20M | $3.34B | $2.10M |
| Share repurchases | $450.00M | $250.10M | $1.00B | $1.10B | $1.67B | $100.00M | $450.00M | $700.00M | $338.10M | $43.90M |
| Investing cash flow | -$1.19B | -$1.37B | -$1.17B | -$1.65B | -$884.60M | -$643.20M | -$1.28B | $206.70M | -$2.23B | -$795.70M |
| Financing cash flow | -$1.46B | $779.90M | -$59.30M | -$1.32B | -$2.07B | -$517.40M | -$252.70M | -$1.39B | $593.20M | -$671.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $563.80M | $445.50M | $191.50M | $614.20M | $387.20M | $620.60M | $18.50M | $777.20M | $277.30M | $561.10M | -$29.80M | $579.60M |
| Capital expenditures | $151.60M | $131.60M | $121.00M | $123.90M | $106.70M | $77.90M | $126.00M | $112.10M | $115.80M | $128.20M | $133.80M | $167.20M |
| Free cash flow | $412.20M | $313.90M | $70.50M | $490.30M | $280.50M | $542.70M | -$107.50M | $665.10M | $161.50M | $432.90M | -$163.60M | $412.40M |
Frequently Asked Questions About LH
What is Labcorp Holdings' annual revenue?
Labcorp Holdings reported revenue of $13.95B for the fiscal year ended Dec 31, 2025.
How fast is Labcorp Holdings' revenue growing?
Revenue was up 7.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.6%.
Is Labcorp Holdings profitable?
Yes. Labcorp Holdings reported net income of $877.70M for the fiscal year ended Dec 31, 2025, with a net margin of 6.3%.
How much free cash flow does LH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.64B minus capital expenditures of $434.50M produced free cash flow of $1.21B.
How much debt does Labcorp Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $5.08B, short-term debt of $500.10M and cash and equivalents of $532.30M.
LH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts